GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Forward Dividend Yield %

COTQF (Cotinga Pharmaceuticals) Forward Dividend Yield % : 0.00% (As of Sep. 24, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Forward Dividend Yield %?

As of today (2024-09-24), the Forward Annual Dividend Yield of Cotinga Pharmaceuticals is 0.00%.

As of today (2024-09-24), the Trailing Annual Dividend Yield of Cotinga Pharmaceuticals is 0.00%.

COTQF's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.575
* Ranked among companies with meaningful Forward Dividend Yield % only.

Cotinga Pharmaceuticals's Dividends per Share for the three months ended in Jan. 2020 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Cotinga Pharmaceuticals's Forward Dividend Yield %

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cotinga Pharmaceuticals's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Forward Dividend Yield % falls into.



Cotinga Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Cotinga Pharmaceuticals  (OTCPK:COTQF) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Cotinga Pharmaceuticals Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cotinga Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire 05-22-2019